Intercellular adhesion molecule-1 (ICAM-1): From molecular functions to clinical applications in cancer investigation
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024-11 · 1879 (6) · 189187
DOI: 10.1016/j.bbcan.2024.189187 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024-11. Verfasst von Wen-Jing Qian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Intercellular Adhesion Molecule-1, Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 208 Literaturangaben.
Abstract (Originalsprache)
Intercellular adhesion molecule-1 (ICAM-1) is a versatile molecule that plays a critical role in various physiological and pathological processes, particularly in tumor development where its impact is bidirectional. On the one hand, it augments the immune response by promoting immune cell migration, infiltration, and the formation of immunological synapses, thus facilitating potent antitumor effects. Simultaneously, it contributes to tumor immune evasion and influences metastasis by mediating transendothelial migration (TEM), epithelial-to-mesenchymal transition (EMT), and epigenetic modification of tumor cells. Despite its significant potential, the full clinical utility of ICAM-1 has yet to be fully realized. In this review, we thoroughly examine recent advancements in understanding the role of ICAM-1 in tumor development, its relevance in predicting therapeutic efficacy and prognosis, as well as the progress in clinical translational research on anti-ICAM-1-based therapies, encompassing including monoclonal antibodies, immunotherapy, antibody-drug conjugate (ADC), and conventional treatments. By shedding light on these innovative strategies, we aim to underscore ICAM-1's significance as a valuable and multifaceted target for cancer treatment, igniting enthusiasm for further research and facilitating translation into clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
- Network Information Center, China Medical University, Shenyang, China.
- Psychological Medicine, Shenyang Medical College, Shenyang, China.
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China; Guangdong Association of Clinical Trials (GACT)/Chinese Thoracic Oncology Group (CTONG) and Guangdong Provincial Ke…
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China. Electronic address: zhaomf618@126.com.
Zitieren
APA
Qian, W. J., Yan, J. S., Gang, X. Y., Xu, L., Shi, S., Li, X., Na, F. J., Cai, L. T., Li, H. M., & Zhao, M. F. (2024). Intercellular adhesion molecule-1 (ICAM-1): From molecular functions to clinical applications in cancer investigation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1879(6), 189187. https://doi.org/10.1016/j.bbcan.2024.189187
Vancouver
Qian WJ, Yan JS, Gang XY, Xu L, Shi S, Li X, et al. Intercellular adhesion molecule-1 (ICAM-1): From molecular functions to clinical applications in cancer investigation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024;1879(6):189187. doi:10.1016/j.bbcan.2024.189187
BibTeX
@article{Qian2024,
author = {Qian, Wen-Jing and Yan, Jin-Shan and Gang, Xiao-Yu and Xu, Lu and Shi, Sha and Li, Xin and Na, Fang-Jian and Cai, Lu-Tong and Li, He-Ming and Zhao, Ming-Fang},
title = {Intercellular adhesion molecule-1 (ICAM-1): From molecular functions to clinical applications in cancer investigation},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2024},
volume = {1879},
number = {6},
pages = {189187},
doi = {10.1016/j.bbcan.2024.189187}
}
EUVIMED